Published in J Clin Microbiol on December 12, 2007
The changing microbial epidemiology in cystic fibrosis. Clin Microbiol Rev (2010) 4.22
Melanized fungi in human disease. Clin Microbiol Rev (2010) 2.89
The airway microbiota in cystic fibrosis: a complex fungal and bacterial community--implications for therapeutic management. PLoS One (2012) 1.80
Species-specific antifungal susceptibility patterns of Scedosporium and Pseudallescheria species. Antimicrob Agents Chemother (2012) 1.62
Population-based survey of filamentous fungi and antifungal resistance in Spain (FILPOP Study). Antimicrob Agents Chemother (2013) 1.22
Development of an oligonucleotide array for direct detection of fungi in sputum samples from patients with cystic fibrosis. J Clin Microbiol (2008) 1.15
Disseminated Scedosporium/Pseudallescheria infection after double-lung transplantation in patients with cystic fibrosis. J Clin Microbiol (2010) 1.03
Identification of Pseudallescheria and Scedosporium species by three molecular methods. J Clin Microbiol (2010) 0.94
Detection of (1-->3)-beta-D-glucan as an adjunct to diagnosis in a mixed population with uncommon proven invasive fungal diseases or with an unusual clinical presentation. Clin Vaccine Immunol (2009) 0.94
Rapid identification of Pseudallescheria and Scedosporium strains by using rolling circle amplification. Appl Environ Microbiol (2011) 0.92
Development and validation of a multiplex PCR for detection of Scedosporium spp. in respiratory tract specimens from patients with cystic fibrosis. J Clin Microbiol (2011) 0.89
Detection of occult Scedosporium species in respiratory tract specimens from patients with cystic fibrosis by use of selective media. J Clin Microbiol (2009) 0.89
Effective Prolonged Therapy with Voriconazole in a Lung Transplant Recipient with Spondylodiscitis Induced by Scedosporium apiospermum. Case Rep Infect Dis (2011) 0.88
Fatal mycotic aneurysms due to Scedosporium and Pseudallescheria infection. J Clin Microbiol (2011) 0.87
Tracking the emerging human pathogen Pseudallescheria boydii by using highly specific monoclonal antibodies. Clin Vaccine Immunol (2009) 0.87
A Rare Presentation of Concurrent Scedosporium apiospermum and Madurella grisea Eumycetoma in an Immunocompetent Host. Case Rep Pathol (2012) 0.86
Emerging fungal infections in solid organ transplant recipients. Infect Dis Clin North Am (2013) 0.84
Susceptibility and diversity in the therapy-refractory genus scedosporium. Antimicrob Agents Chemother (2014) 0.82
Externa otitis caused by the Graphium stage of Pseudallescheria apiosperma. Med Mycol Case Rep (2013) 0.80
Graphium basitruncatum fungemia in an immunosuppressed child post stem-cell transplantation. Med Mycol Case Rep (2012) 0.79
Experimental murine scedosporiosis: histopathology and azole treatment. Antimicrob Agents Chemother (2010) 0.79
Phenotypic profiling of Scedosporium aurantiacum, an opportunistic pathogen colonizing human lungs. PLoS One (2015) 0.78
Environmental Screening for the Scedosporium apiospermum Species Complex in Public Parks in Bangkok, Thailand. PLoS One (2016) 0.77
Fungal Planet description sheets: 469-557. Persoonia (2016) 0.77
Pseudallescheria fusoidea, a new cause of osteomyelitis. J Clin Microbiol (2008) 0.77
Scedosporium apiosermum infection of the "Native" valve: Fungal endocarditis in an orthotopic heart transplant recipient. Med Mycol Case Rep (2015) 0.76
A Multifaceted Study of Scedosporium boydii Cell Wall Changes during Germination and Identification of GPI-Anchored Proteins. PLoS One (2015) 0.76
Prospective multicenter German study on pulmonary colonization with Scedosporium /Lomentospora species in cystic fibrosis: Epidemiology and new association factors. PLoS One (2017) 0.75
Labeled Trichoderma reesei cellulase as a marker for Acanthamoeba cyst wall cellulose in infected tissues. Appl Environ Microbiol (2009) 0.75
Secretion of Proteases by an Opportunistic Fungal Pathogen Scedosporium aurantiacum. PLoS One (2017) 0.75
Cell wall modifications during conidial maturation of the human pathogenic fungus Pseudallescheria boydii. PLoS One (2014) 0.75
Purification and characterization of a mycelial catalase from Scedosporium boydii, a useful tool for specific antibody detection in patients with cystic fibrosis. Clin Vaccine Immunol (2014) 0.75
DnaSP, DNA polymorphism analyses by the coalescent and other methods. Bioinformatics (2003) 32.63
Concordance of gene genealogies reveals reproductive isolation in the pathogenic fungus Coccidioides immitis. Proc Natl Acad Sci U S A (1997) 2.91
Molecular phylogeny of the Pseudallescheria boydii species complex: proposal of two new species. J Clin Microbiol (2005) 2.83
Developments in fungal taxonomy. Clin Microbiol Rev (1999) 2.39
Cryptic speciation in the cosmopolitan and clonal human pathogenic fungus Aspergillus fumigatus. Evolution (2005) 2.37
Genetic variation in Pneumocystis carinii isolates from different geographic regions: implications for transmission. Emerg Infect Dis (2000) 2.08
Species of Phaeoacremonium associated with infections in humans and environmental reservoirs in infected woody plants. J Clin Microbiol (2005) 1.98
Antifungal susceptibilities of the species of the Pseudallescheria boydii complex. Antimicrob Agents Chemother (2006) 1.74
Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species. J Clin Microbiol (2004) 4.70
Necrotizing cutaneous mucormycosis after a tornado in Joplin, Missouri, in 2011. N Engl J Med (2012) 3.26
Melanized fungi in human disease. Clin Microbiol Rev (2010) 2.89
Molecular phylogeny of the Pseudallescheria boydii species complex: proposal of two new species. J Clin Microbiol (2005) 2.83
Disseminated phaeohyphomycosis: review of an emerging mycosis. Clin Infect Dis (2002) 2.70
Infections caused by Scedosporium spp. Clin Microbiol Rev (2008) 2.69
Primary central nervous system phaeohyphomycosis: a review of 101 cases. Clin Infect Dis (2003) 2.62
Sporothrix brasiliensis, S. globosa, and S. mexicana, three new Sporothrix species of clinical interest. J Clin Microbiol (2007) 2.57
Phenotypic and molecular characterization of Candida nivariensis sp. nov., a possible new opportunistic fungus. J Clin Microbiol (2005) 2.52
Sequence-based identification of filamentous basidiomycetous fungi from clinical specimens: a cautionary note. J Clin Microbiol (2009) 2.44
Molecular phylogenetic diversity, multilocus haplotype nomenclature, and in vitro antifungal resistance within the Fusarium solani species complex. J Clin Microbiol (2008) 2.16
Phylogenetic diversity and microsphere array-based genotyping of human pathogenic Fusaria, including isolates from the multistate contact lens-associated U.S. keratitis outbreaks of 2005 and 2006. J Clin Microbiol (2007) 2.02
Members of the Fusarium solani species complex that cause infections in both humans and plants are common in the environment. J Clin Microbiol (2006) 1.99
Species of Phaeoacremonium associated with infections in humans and environmental reservoirs in infected woody plants. J Clin Microbiol (2005) 1.98
In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents. Antimicrob Agents Chemother (2007) 1.85
Development and validation of a high-performance liquid chromatography assay for voriconazole. Antimicrob Agents Chemother (2003) 1.77
Molecular phylogeny of Sporothrix schenckii. J Clin Microbiol (2006) 1.76
Antifungal susceptibilities of the species of the Pseudallescheria boydii complex. Antimicrob Agents Chemother (2006) 1.74
Fusarium oxysporum as a multihost model for the genetic dissection of fungal virulence in plants and mammals. Infect Immun (2004) 1.67
Disseminated Geosmithia argillacea infection in a German shepherd dog. Med Mycol (2009) 1.62
Epidemiology and outcome of Scedosporium prolificans infection, a review of 162 cases. Med Mycol (2009) 1.61
In vitro antifungal susceptibilities of five species of sporothrix. Antimicrob Agents Chemother (2007) 1.60
Two cases of subcutaneous infection due to Phaeoacremonium spp. J Clin Microbiol (2003) 1.53
Pseudallescheria boydii (Anamorph Scedosporium apiospermum). Infection in solid organ transplant recipients in a tertiary medical center and review of the literature. Medicine (Baltimore) (2002) 1.53
Internet-accessible DNA sequence database for identifying fusaria from human and animal infections. J Clin Microbiol (2010) 1.51
Molecular identification and in vitro response to antifungal drugs of clinical isolates of Exserohilum. Antimicrob Agents Chemother (2012) 1.51
A two-locus DNA sequence database for typing plant and human pathogens within the Fusarium oxysporum species complex. Fungal Genet Biol (2009) 1.41
Molecular phylogenetic diversity of the emerging mucoralean fungus Apophysomyces: proposal of three new species. Rev Iberoam Micol (2010) 1.40
Geosmithia argillacea: an emerging cause of invasive mycosis in human chronic granulomatous disease. Clin Infect Dis (2011) 1.39
In vitro antifungal susceptibility of Cryptococcus gattii. J Clin Microbiol (2004) 1.39
Sporothrix luriei: a rare fungus from clinical origin. Med Mycol (2008) 1.38
Molecular and morphological identification of Colletotrichum species of clinical interest. J Clin Microbiol (2004) 1.35
Universal in vitro antifungal resistance of genetic clades of the Fusarium solani species complex. Antimicrob Agents Chemother (2007) 1.31
PCR protocol for specific identification of Candida nivariensis, a recently described pathogenic yeast. J Clin Microbiol (2005) 1.25
Phialosimplex, a new anamorphic genus associated with infections in dogs and having phylogenetic affinity to the Trichocomaceae. Med Mycol (2010) 1.24
Taxonomy and phylogeny of the Fusarium dimerum species group. Mycologia (2009) 1.24
Collaborative evaluation of optimal antifungal susceptibility testing conditions for dermatophytes. J Clin Microbiol (2002) 1.23
Novel multilocus sequence typing scheme reveals high genetic diversity of human pathogenic members of the Fusarium incarnatum-F. equiseti and F. chlamydosporum species complexes within the United States. J Clin Microbiol (2009) 1.22
In vitro interactions of approved and novel drugs against Paecilomyces spp. Antimicrob Agents Chemother (2004) 1.22
Sporothrix globosa, a pathogenic fungus with widespread geographical distribution. Rev Iberoam Micol (2009) 1.21
Cerebral aspergillosis caused by Neosartorya hiratsukae, Brazil. Emerg Infect Dis (2002) 1.20
One fungus, one name: defining the genus Fusarium in a scientifically robust way that preserves longstanding use. Phytopathology (2013) 1.19
Posaconazole combined with amphotericin B, an effective therapy for a murine disseminated infection caused by Rhizopus oryzae. Antimicrob Agents Chemother (2008) 1.18
Adiaspiromycosis causing respiratory failure and a review of human infections due to Emmonsia and Chrysosporium spp. J Clin Microbiol (2012) 1.18
Isolation and identification of yeasts associated with vineyard and winery by RFLP analysis of ribosomal genes and mitochondrial DNA. Microbiol Res (2002) 1.17
Correlation between in vitro susceptibility of Scedosporium apiospermum to voriconazole and in vivo outcome of scedosporiosis in guinea pigs. Antimicrob Agents Chemother (2004) 1.16
Efficacy of voriconazole in treatment of systemic scedosporiosis in neutropenic mice. Antimicrob Agents Chemother (2003) 1.16
Whole genome sequence typing to investigate the Apophysomyces outbreak following a tornado in Joplin, Missouri, 2011. PLoS One (2012) 1.16
Presence of Arcobacter spp. in environmental waters correlates with high levels of fecal pollution. Environ Microbiol (2008) 1.15
Trichosporon mycotoxinivorans, a novel respiratory pathogen in patients with cystic fibrosis. J Clin Microbiol (2009) 1.14
Prevalence of Arcobacter in meat and shellfish. J Food Prot (2009) 1.14
Correlation of antifungal susceptibility and molecular type within the Cryptococcus neoformans/C. gattii species complex. Med Mycol (2011) 1.13
Actinomucor elegans var. kuwaitiensis isolated from the wound of a diabetic patient. Antonie Van Leeuwenhoek (2008) 1.12
Scopulariopsis, a poorly known opportunistic fungus: spectrum of species in clinical samples and in vitro responses to antifungal drugs. J Clin Microbiol (2013) 1.11
In vitro activities of new and established triazoles against opportunistic filamentous and dimorphic fungi. Med Mycol (2005) 1.11
Fungal endophthalmitis caused by Aspergillus ustus in a patient following cataract surgery. Med Mycol (2006) 1.10
Saksenaea vasiformis infections: case report and literature review. Mycopathologia (2006) 1.09
Genus Hamigera, six new species and multilocus DNA sequence based phylogeny. Mycologia (2010) 1.08
In vitro antifungal susceptibilities of Sporothrix schenckii in two growth phases. Antimicrob Agents Chemother (2005) 1.07
Role of the white collar 1 photoreceptor in carotenogenesis, UV resistance, hydrophobicity, and virulence of Fusarium oxysporum. Eukaryot Cell (2008) 1.06
HapX-mediated iron homeostasis is essential for rhizosphere competence and virulence of the soilborne pathogen Fusarium oxysporum. Plant Cell (2012) 1.06
The velvet complex governs mycotoxin production and virulence of Fusarium oxysporum on plant and mammalian hosts. Mol Microbiol (2012) 1.06
Two new species of Mucor from clinical samples. Med Mycol (2010) 1.05
Genotyping of Scedosporium species: a review of molecular approaches. Med Mycol (2008) 1.05
Efficacy of micafungin in combination with other drugs in a murine model of disseminated trichosporonosis. Antimicrob Agents Chemother (2005) 1.05
Corneal ulcer caused by the new fungal species Sarcopodium oculorum. J Clin Microbiol (2002) 1.05